Promoter methylation and down-regulation of DAPK is associated with gastric atrophy
- PMID: 14612952
Promoter methylation and down-regulation of DAPK is associated with gastric atrophy
Abstract
Promoter methylation of death-associated protein kinase (DAPK) occurs frequently in cancer cells, which results in the decreased transcription of DAPK. Although promoter methylation of DAPK has been previously reported, it has not been explored in the surrounding normal tissues of gastric cancer patients. Herein we have examined whether the promoter methylation of DAPK gene or down-modulation of DAPK is associated with gastric atrophy. Thirty-nine samples of surgically resected gastric carcinomas and corresponding non-tumorous tissues were studied. Methylation-specific polymerase chain reaction was performed to test DAPK promoter methylation. We evaluated the expression level of DAPK protein in normal and atrophic gastric tissue by both Western blot analysis and immunohistochemical staining. Significant correlation was not observed between methylation and an advanced pathological stage of tumor. No association was found between promoter methylation of DAPK and Helicobacter pylori infection, whereas a close association was observed with the presence of gastric atrophy and DAPK promoter methylation (P=0.015). The level of DAPK protein expression was significantly low in atrophic gastritis compared with those without atrophy (P=0.003). Collectively, DAPK promoter methylation and down-regulation is tightly associated with gastric atrophy, which often contributes to the preneoplastic changes in gastric carcinogenesis.
Similar articles
-
Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.Laryngoscope. 2005 Aug;115(8):1395-401. doi: 10.1097/01.MLG.0000166708.23673.3A. Laryngoscope. 2005. PMID: 16094112
-
Epigenetic regulation of death-associated protein kinase expression in primary gastric cancers from Chinese patients.Eur J Cancer Prev. 2012 May;21(3):241-6. doi: 10.1097/CEJ.0b013e32834c9caa. Eur J Cancer Prev. 2012. PMID: 21979297
-
Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.Hum Pathol. 2009 Nov;40(11):1534-42. doi: 10.1016/j.humpath.2009.01.029. Epub 2009 Aug 19. Hum Pathol. 2009. PMID: 19695681
-
Clinical effect of DAPK promoter methylation in gastric cancer: A systematic meta-analysis.Medicine (Baltimore). 2016 Oct;95(43):e5040. doi: 10.1097/MD.0000000000005040. Medicine (Baltimore). 2016. PMID: 27787359 Free PMC article. Review.
-
Transcription control of DAPK.Apoptosis. 2014 Feb;19(2):298-305. doi: 10.1007/s10495-013-0931-6. Apoptosis. 2014. PMID: 24217921 Review.
Cited by
-
Control of death-associated protein kinase (DAPK) activity by phosphorylation and proteasomal degradation.J Biol Chem. 2006 Dec 22;281(51):39033-40. doi: 10.1074/jbc.M605097200. Epub 2006 Oct 20. J Biol Chem. 2006. PMID: 17056602 Free PMC article.
-
Influence of HRH2 promoter polymorphism on aberrant DNA methylation of DAPK and CDH1 in the gastric epithelium.BMC Gastroenterol. 2013 Jan 2;13:1. doi: 10.1186/1471-230X-13-1. BMC Gastroenterol. 2013. PMID: 23280118 Free PMC article.
-
Analysis of APC mutation in human ameloblastoma and clinical significance.Springerplus. 2016 Mar 10;5:314. doi: 10.1186/s40064-016-1904-3. eCollection 2016. Springerplus. 2016. PMID: 27065015 Free PMC article.
-
Aberrant hydroxymethylation in promoter CpG regions of genes related to the cell cycle and apoptosis characterizes advanced chronic myeloid leukemia disease, poor imatinib respondents and poor survival.BMC Cancer. 2022 Apr 14;22(1):405. doi: 10.1186/s12885-022-09481-9. BMC Cancer. 2022. PMID: 35421941 Free PMC article.
-
Promoter methylation in the genesis of gastrointestinal cancer.Yonsei Med J. 2009 Jun 30;50(3):309-21. doi: 10.3349/ymj.2009.50.3.309. Epub 2009 Jun 23. Yonsei Med J. 2009. PMID: 19568590 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical